Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ADMA | ADMA Biologics, Inc.

IndexRUT P/E- EPS (ttm)-0.20 Insider Own1.50% Shs Outstand222.68M Perf Week-6.33%
Market Cap809.08M Forward P/E30.34 EPS next Y0.12 Insider Trans-41.53% Shs Float202.66M Perf Month-12.13%
Income-40.30M PEG- EPS next Q-0.01 Inst Own67.30% Short Float / Ratio4.37% / 4.11 Perf Quarter-10.13%
Sales208.10M P/S3.89 EPS this Y35.10% Inst Trans7.42% Short Interest8.86M Perf Half Y14.52%
Book/sh0.66 P/B5.38 EPS next Y271.40% ROA-12.10% Target Price6.00 Perf Year37.07%
Cash/sh0.27 P/C12.95 EPS next 5Y- ROE-29.60% 52W Range2.24 - 4.65 Perf YTD-8.51%
Dividend- P/FCF- EPS past 5Y29.50% ROI-15.60% 52W High-23.66% Beta0.81
Dividend %- Quick Ratio2.50 Sales past 5Y46.60% Gross Margin27.40% 52W Low58.48% ATR0.15
Employees617 Current Ratio6.30 Sales Q/Q77.30% Oper. Margin-8.00% RSI (14)34.29 Volatility3.77% 3.76%
OptionableYes Debt/Eq0.96 EPS Q/Q59.20% Profit Margin-19.40% Rel Volume0.74 Prev Close3.65
ShortableYes LT Debt/Eq0.96 EarningsAug 09 AMC Payout- Avg Volume2.16M Price3.55
Recom1.70 SMA20-7.19% SMA50-9.44% SMA200-3.19% Volume1,584,942 Change-2.74%
Date Action Analyst Rating Change Price Target Change
Jul-19-23Resumed Raymond James Strong Buy $5
Oct-13-22Initiated Mizuho Buy $5
Nov-11-21Upgrade Raymond James Outperform → Strong Buy $5
Nov-09-21Initiated Cantor Fitzgerald Overweight $4.50
Jun-04-19Initiated Jefferies Buy $8
Apr-15-19Reiterated H.C. Wainwright Buy $10 → $13
Feb-07-19Resumed H.C. Wainwright Buy $10
Dec-11-17Reiterated Maxim Group Buy $13 → $8
Nov-14-17Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17Upgrade Maxim Group Hold → Buy $13
Dec-01-14Reiterated Maxim Group Buy $16 → $18
Sep-14-23 05:50PM
Sep-13-23 09:30AM
Aug-10-23 02:31PM
06:46AM Loading…
Aug-09-23 06:40PM
Aug-02-23 07:00AM
Jul-28-23 08:59AM
Jul-26-23 11:30AM
Jul-25-23 05:12PM
Jul-20-23 05:50PM
Jul-19-23 07:00AM
05:50PM Loading…
Jul-13-23 05:50PM
Jul-07-23 07:32AM
Jun-23-23 10:31AM
Jun-22-23 09:18AM
Jun-21-23 03:21PM
Jun-19-23 10:28AM
Jun-16-23 10:43AM
Jun-14-23 12:17PM
Jun-13-23 09:18AM
Jun-08-23 11:49AM
12:31PM Loading…
Jun-07-23 12:31PM
Jun-06-23 11:14AM
Jun-05-23 12:43PM
Jun-02-23 10:59AM
Jun-01-23 11:59AM
May-31-23 10:46AM
May-30-23 10:56AM
May-29-23 09:40AM
May-26-23 08:23AM
May-25-23 03:16PM
May-24-23 11:37AM
May-22-23 11:05AM
May-18-23 11:15AM
May-17-23 02:19PM
May-12-23 09:40AM
May-11-23 09:35AM
May-10-23 05:15PM
May-03-23 11:55AM
May-02-23 07:00AM
Apr-18-23 11:43AM
Apr-17-23 03:25PM
Apr-12-23 10:42AM
Mar-27-23 07:08AM
Mar-26-23 09:22AM
Mar-24-23 09:37AM
Mar-23-23 05:45PM
Mar-16-23 07:00AM
Mar-03-23 09:48AM
Mar-01-23 09:36AM
Feb-28-23 09:10AM
Feb-19-23 02:05PM
Feb-12-23 10:56AM
Feb-08-23 07:00AM
Feb-07-23 10:17AM
Jan-17-23 07:00AM
Dec-28-22 11:58PM
Dec-13-22 07:00AM
Dec-11-22 08:41AM
Dec-09-22 04:05PM
Dec-07-22 08:45AM
Dec-06-22 04:05PM
Nov-30-22 02:47PM
Nov-11-22 05:28AM
Nov-09-22 05:35PM
Nov-02-22 07:00AM
Oct-31-22 07:00AM
Oct-17-22 07:05AM
Sep-23-22 02:25PM
Sep-15-22 03:00PM
Aug-11-22 06:08PM
Aug-10-22 05:25PM
Aug-08-22 10:00AM
Aug-03-22 10:00AM
Jun-26-22 09:11AM
Jun-21-22 07:00AM
May-11-22 05:45PM
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grossman Jerrold BDirectorAug 30Buy3.71130,000482,144443,265Aug 30 04:58 PM
KWON YOUNGDirectorAug 24Buy3.9025,00097,500277,401Aug 24 07:53 PM
Fong BryantDirectorAug 22Sale3.871,433,3045,544,7370Aug 23 08:30 PM
Grossman Adam SPresident and CEOAug 18Sale4.15250,0001,038,3502,273,085Aug 18 09:46 PM
LENZ BRIANEVP, CFOAug 16Sale4.45178,184793,400782,013Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 16Sale4.383132,523,085Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 15Option Exercise3.112,100,4596,536,4484,623,544Aug 17 09:30 PM
LENZ BRIANEVP, CFOAug 15Option Exercise3.11809,2622,514,3631,591,275Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 15Sale4.54510,4692,318,9594,113,075Aug 17 09:30 PM
LENZ BRIANEVP, CFOAug 15Sale4.60211,578972,730782,013Aug 17 09:30 PM
Grossman Adam SPresident and CEODec 09Buy2.8614,98342,8512,203,708Dec 09 04:41 PM
Grossman Adam SPresident and CEODec 09Buy2.8614,98242,8491,143,426Dec 09 04:41 PM
LENZ BRIANEVP, CFODec 09Buy2.866,99320,0001,034,825Dec 09 04:41 PM